首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1538721篇
  免费   124683篇
  国内免费   6940篇
耳鼻咽喉   18936篇
儿科学   48206篇
妇产科学   40349篇
基础医学   208977篇
口腔科学   40153篇
临床医学   141377篇
内科学   319412篇
皮肤病学   34696篇
神经病学   130887篇
特种医学   63928篇
外国民族医学   287篇
外科学   241058篇
综合类   33711篇
现状与发展   3篇
一般理论   579篇
预防医学   120844篇
眼科学   32929篇
药学   107025篇
  6篇
中国医学   2513篇
肿瘤学   84468篇
  2021年   13133篇
  2019年   13296篇
  2018年   18504篇
  2017年   14383篇
  2016年   16891篇
  2015年   19130篇
  2014年   26964篇
  2013年   39236篇
  2012年   50852篇
  2011年   54176篇
  2010年   32987篇
  2009年   31871篇
  2008年   49994篇
  2007年   53031篇
  2006年   53819篇
  2005年   52275篇
  2004年   49733篇
  2003年   47651篇
  2002年   45242篇
  2001年   67655篇
  2000年   69083篇
  1999年   58271篇
  1998年   19043篇
  1997年   16859篇
  1996年   17588篇
  1995年   17628篇
  1994年   16317篇
  1993年   15333篇
  1992年   47876篇
  1991年   46455篇
  1990年   44568篇
  1989年   42372篇
  1988年   39280篇
  1987年   38559篇
  1986年   36340篇
  1985年   35172篇
  1984年   27081篇
  1983年   22749篇
  1982年   14690篇
  1981年   13255篇
  1980年   12406篇
  1979年   23916篇
  1978年   17497篇
  1977年   14752篇
  1976年   13540篇
  1975年   13993篇
  1974年   16357篇
  1973年   15625篇
  1972年   14319篇
  1971年   13168篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
65.
66.

Objectives

To investigate whether functional overreaching affects locomotor system behaviour when running at fixed relative intensities and if any effects were associated with changes in running performance.

Design

Prospective intervention study.

Methods

Ten trained male runners completed three training blocks in a fixed order. Training consisted of one week of light training (baseline), two weeks of heavy training designed to induce functional overreaching, and ten days of light taper training designed to allow athletes to recover from, and adapt to, the heavy training. Locomotor behaviour, 5-km time trial performance, and subjective reports of training status (Daily Analysis of Life Demands for Athletes (DALDA) questionnaire) were assessed at the completion of each training block. Locomotor behaviour was assessed using detrended fluctuation analysis of stride intervals during running at speeds corresponding to 65% and 85% of maximum heart rate (HRmax) at baseline.

Results

Time trial performance (effect size ±95% confidence interval (ES): 0.16 ± 0.06; p < 0.001), locomotor behaviour at 65% HRmax (ES: ?1.12 ± 0.95; p = 0.026), and DALDA (ES: 2.55 ± 0.80; p < 0.001) were all detrimentally affected by the heavy training. Time trial performance improved relative to baseline after the taper (ES: ?0.16 ± 0.10; p = 0.003) but locomotor behaviour at 65% HRmax (ES: ?1.18 ± 1.17; p = 0.048) and DALDA (ES: 0.92 ± 0.90; p = 0.045) remained impaired.

Conclusions

Locomotor behaviour during running at 65% HRmax was impaired by functional overreaching and remained impaired after a 10-day taper, despite improved running performance. Locomotor changes may increase injury risk and should be considered within athlete monitoring programs independently of performance changes.  相似文献   
67.
68.
69.
70.

Objective

To determine whether differences in combination DTaP vaccine types at 2, 4 and 6?months of age were associated with mortality (all-cause or non-specific), within 30?days of vaccination.

Design

Observational nationwide cohort study.

Setting

Linked population data from the Australian Childhood Immunisation Register and National Death Index.

Participants

Australian infants administered a combination trivalent, quadrivalent or hexavalent DTaP vaccine (DTaP types) between January 1999 and December 2010 at 2, 4 and 6?months as part of the primary vaccination series. The study population included 2.9, 2.6, & 2.3?million children in the 2, 4 and 6?month vaccine cohorts, respectively.

Main outcome measures

Infants were evaluated for the primary outcome of all-cause mortality within 30?days. A secondary outcome was non-specific mortality (unknown cause of death) within 30?days of vaccination. Non-specific mortality was defined as underlying or other cause of death codes, R95 ‘Sudden infant death syndrome’, R96 ‘Other sudden death, cause unknown’, R98 ‘Unattended death’, R99 ‘Other ill-defined and unspecified cause of mortality’ or where no cause of death was recorded.

Results

The rate of 30?day all-cause mortality was low and declined from 127.4 to 59.3 deaths per 100,000 person-years between 2 and 6?month cohorts. When compared with trivalent DTaP vaccines, no elevated risk in all-cause or non-specific mortality was seen with any quadrivalent or hexavalent DTaP vaccines, for any cohort.

Conclusion

Use of routine DTaP combination vaccines with differing disease antigens administered during the first six months of life is not associated with infant mortality.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号